Work

Clinical and Biomarker Outcomes of the Phase II Vandetanib Study from the BATTLE Trial

Year: 2013

Type: article

Source: Journal of Thoracic Oncology

DOI: 10.1097/jto.0b013e31828d08ae

Authors: Anne S. Tsao, Suyu Liu, J. Jack Lee, Christine M. Alden, George R. Blumenschein, Roy Herbst, Suzanne E. Davis, Edward Kim, Scott Lippman, John Heymach, Hai Tran, XiMing Tang, Ignacio Wistuba, Waun Ki Hong

Institutions: The University of Texas MD Anderson Cancer Center, Yale Cancer Center

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funder: National Cancer Institute

Awards: G111615301, G995644284

OpenAlex ID: W2154377120

FWCI: 2.442

Cites: 15

Cited by: 22

Related to: 10